Researcher
Lore Decoster
- Keywords:Medicine
- Disciplines:Cancer diagnosis, Cancer therapy
Affiliations
- Medical Oncology (Department)
Member
From1 Jun 2010 → Today - Laboratory for Medical and Molecular Oncology (Research group)
Member
From1 Jan 2010 → Today - Clinical sciences (Department)
Member
From1 Oct 2020 → Today - Clinical sciences (Department)
Member
From1 Oct 2020 → 20 Oct 2022 - Clinical sciences (Department)
Member
From1 Oct 2019 → 30 Sep 2022 - Clinical sciences (Department)
Member
From1 Oct 2019 → 30 Sep 2022 - Faculty of Medicine and Pharmacy (Faculty)
Member
From8 Dec 2016 → 5 Sep 2019 - Clinical sciences (Department)
Member
From1 May 2012 → 30 Apr 2018
Projects
1 - 1 of 1
- Interdisciplinary Network in Fundamental and Medical Research on Lung and Pancreatic Cancer [NITROGEN]From1 Jul 2021 → TodayFunding: BOF - projects
Publications
41 - 50 of 57
- Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation(2016)
Authors: Jacques De Grève, Jan Van Meerbeeck, Johan F Vansteenkiste, Lore Decoster, Anne-Pascale Meert, Peter Vuylsteke, Christian Focan, Jean-Luc Canon, Yves Humblet, Guy Berchem, et al.
- A Belgian Survey on Geriatric Assessment in Oncology Focusing on Large-Scale Implementation and Related Barriers and Facilitators(2016)
Authors: C. Kenis, P. Heeren, Lore Decoster, Katrien Van Puyvelde, G. Conings, Fabienne Cornelis, P. Cornette, R. Moor, S. Luce, Y. Libert, et al.
Pages: 60-70 - Implementation of geriatric assessment-based recommendations in older patients with cancer(2015)
Authors: Abdelbari Baitar, Cindy Kenis, Ramona Moor, Lore Decoster, Sylvie Luce, Dominique Bron, Ruud Van Rijswijk, Marika Rasschaert, Christine Langenaeken, Guy Jerusalem, et al.
Pages: 401-410 - Phase II study of afatinib, an irreversible ErbB family blocker, in demographically and genotypically defined lung adenocarcinoma(2015)
Authors: Jacques De Grève, Teresa Moran, Marie-Pascale Graas, Daniella Galdermans, Peter Vuylsteke, Jean-Luc Canon, Denis Schallier, Lore Decoster, Erik Teugels, Dan Massey, et al.
Pages: 63-69 - Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients(2015)
Authors: Lore Decoster, Karolien Van Puyvelde, S. Mohile, U. Wedding, U. Basso, G. Colloca, S. Rostoft, J. Overcash, Hans Wildiers, C. Steer, et al.
Pages: 288-300 - Shifts in subsets of CD8+ T-cells as evidence of immunosenescence in patients with cancers affecting the lungs(2015)
Authors: Oscar Onyema, Lore Decoster, Rose Njemini, Louis Nuvagah Forti, Ivan Bautmans, Marc De Waele, Tony Mets
- Fall predictors in older cancer patients: a multicenter prospective study(2014)
Authors: Nathalie Vandewalle, Cindy Kenis, Katrien Van Puyvelde, Lore Decoster, Ingo Beyer, G. Conings, Johan Flamaing, J.p. Lobelle, Hans Wildiers, K. Milisen
Pages: 135 - Comparison of a gene expression profiling strategy to standard clinical work-up for determination of tumour origin in cancer of unknown primary (CUP)(2013)
Authors: Felipe Ades, E. De Azambuja, G. Daugaard, L. Ameye, C. Moulin, M. Paesmans, D. De Jong, Lore Decoster, Jacques De Grève, G. Ismael, et al.
Pages: 239-246 - Relevance of a systematic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric study
DOI: 10.1093/annonc/mds619
Published: MAY 2013(2013)
Authors: C. Kenis, D. Bron, Y. Libert, Lore Decoster
Pages: 1306-1312 - Evaluation of a comprehensive rehabilitation program for post-treatment patients with cancer.(2011)
Authors: Sophie Hanssens, Rik Luyten, Chris Watthy, Christel Fontaine, Lore Decoster, Catherine Baillon, Fabienne Trullemans, Aisha Cortoos, Jacques De Grève
Pages: 418-424